WebJan 9, 2024 · CinCor stock fell 23% in 2024 after its January IPO debut at $16 per share. It fell 46% in a single day in November after the company said a Phase 2 trial of baxdostrat did not achieve its primary goal of significantly reducing blood pressure in patients with uncontrolled hypertension versus placebo participants. WebJan 3, 2024 · CinCor also intends to grant the underwriters a 30-day option to purchase up to an additional 1,650,000 shares of its common stock at the public offering price, less underwriting discounts and ...
CinCor Pharma Inc (CINC) Stock Price Today, News, …
WebJan 9, 2024 · CinCor stock surges after AstraZeneca announces plan to buy company for up to $1.8B. AstraZeneca (LON:AZN) announced it had reached an agreement to acquire CinCor Pharma (Nasdaq:CINC). After … WebTinta Aquacin GC200 Branco mate 15L Ref. 10-320 CIN. ref: 10-320_15L. €77,90. Tinta aquosa lisa mate, especial para aplicação directa sobre placas de gesso cartonado, que dispensa o uso de primário. Com muito boa opacidade, e com boa relação qualidade/preço. Muito boa aplicabilidade. snitch fit
Acquisition of CinCor Pharma complete MarketScreener
WebFeb 23, 2024 · CinCor Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its lead clinical candidate, CIN-107, for the treatment … WebFeb 24, 2024 · CinCor Pharma Stock Surges on AstraZeneca Deal to Buy It finance.yahoo.com - January 9 at 9:38 AM: Analyzing CinCor Pharma's Short Interest msn.com - January 3 at 5:56 PM: CinCor Pharma Misses The Primary Endpoint, But All Is Not Lost seekingalpha.com - December 30 at 2:48 PM: Goldman Sachs Keeps Their Buy … WebJan 9, 2024 · CinCor stockholders holding approximately 44.8% of CinCor common stock have entered into a tender and support agreement with AstraZeneca, pursuant to which such stockholders have agreed, among other things, to tender 100% of their shares of CinCor common stock in the tender offer, subject to the terms and conditions of such … snitch food